The suppressive role of CTSB on the expression of XYLT1 was further validated by the quantification of CTSB expression in fibroblasts from patients with the inflammation-associated disease Pseudoxanthoma elasticum. This evidence concerns the gene XYLT1 and pseudoxanthoma elasticum (inherited or acquired).